ClinicalTrials.gg
Active, not recruitingNCT07539714DAHDD-TCTUpdated Apr 20, 2026

Development of an Active Heat Dissipation Device Based on Thermoelectric Cooling Technology: Aiming to Improve Endurance Sports Performance

An interventional study of TEC Vest and No Pre-Cooling (Without Vest) in Heat Stroke, sponsored by Kaohsiung Medical University. Active, not recruiting at 1 site in Taiwan. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Kaohsiung Medical University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

This project investigates the effectiveness of pre-exercise active cooling using a temperature-controlled cooling vest in reducing heat-related physiological strain during endurance-type aerobic exercise in non-regularly trained ("weekend") athletes under hot and humid environmental conditions. Because these individuals often lack sufficient heat-acclimation training, they are at increased risk of excessive thermal stress, cardiovascular overload, and heat-related disorders during prolonged exercise.

Using a controlled laboratory design, participants will perform moderate-intensity endurance exercise in a simulated hot environment, with or without pre-cooling intervention. Peripheral circulation and thermoregulatory responses will be assessed through laser Doppler flowmetry based skin blood-flow analysis and infrared thermography, alongside heart rate and perceived exertion measures.

The study aims to clarify how active pre-cooling influences vascular regulation, sympathetic activity, skin temperature distribution, and exercise tolerance, and to evaluate its potential as a practical, non-fatiguing alternative to heat-acclimation training. The findings are expected to provide evidence-based guidance for reducing heat strain and improving exercise safety and comfort in recreational endurance athletes exercising in hot climates.

Read the detailed description

The primary aim of this study is to investigate the effects of pre-exercise active cooling using a temperature-controlled vest on peripheral vascular regulation mechanisms in non-regular endurance exercisers under hot environmental conditions. Specifically, this study seeks to quantify how pre-cooling modulates skin blood-flow dynamics, sympathetic nervous system activity, endothelial function, and myogenic vascular control, as assessed through frequency-domain analysis of laser Doppler flowmetry signals, before and after endurance-type aerobic exercise. By characterizing these microcirculatory responses alongside changes in skin-surface temperature measured via infrared thermography, the study aims to elucidate the physiological pathways through which active pre-cooling attenuates thermal strain and cardiovascular load during exercise in the heat.

02

Conditions studied

  • Heat Stroke

Browse trials for

Keywords

  • Active Cooling Device
03

In context

Heat Stroke

21 studies on the registry are indexed under Heat Stroke; 10 are open to participants now.

This study's planned enrollment of 30 is below the median of 34 across 13 interventional studies indexed under Heat Stroke.

Browse Heat Stroke studies →

Lead sponsor

Kaohsiung Medical University is the lead sponsor of 56 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 20-50 years.
  • In the past 6 months, endurance exercise less than three times per week, 40-60 min each session.
  • No cardiovascular, metabolic (e.g., diabetes), or neurological disorders, and no diseases affecting vascular regulation.
  • No medication affecting vascular tone within the last 3 months.
  • No major musculoskeletal injuries or disorders affecting performance within the last 3 months.

Exclusion criteria

Exclusion Criteria:

    • Diabetes, hypertension, or peripheral vascular disease.

      • Long-term work in hot environments.
      • > 30 kg/m², smoking, or heavy alcohol use.
      • Allergic reactions triggered by heat or cold (e.g., hives).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Arm 1: Pre-Cooling with TEC Vest

    Arm 1: Pre-Cooling with TEC Vest Participants receive pre-cooling using a temperature-controlled cooling vest (tec) for 30 mins prior to the exercise trial.

    Device: TEC Vest

  • Experimental
    No Pre-Cooling (Without Vest)

    Arm 2: No Pre-Cooling Participants complete the same exercise trial without any cooling intervention (no vest).

    Other: No Pre-Cooling (Without Vest)

  • Experimental
    Pre-Cooling with Water Cooled Vest

    Pre-Cooling with Water Cooled Vest Participants receive pre-cooling using a water cooled vest for 30 mins prior to the exercise trial.

    Device: Water Cooled Vest

Interventions

  • DeviceTEC Vest

    Intervention 1: Active Pre-Cooling Vest Type: Device (active cooling garment) Timing: 30 minutes before exercise (pre-cooling period) Procedure: Participants wear the temperature-controlled vest in a hot/humid lab setting before the endurance aerobic exercise test. Purpose: Reduce thermal strain and cardiovascular load; improve comfort; modulate peripheral circulation responses.

  • OtherNo Pre-Cooling (Without Vest)

    Intervention 2: No Pre-Cooling Without Vest Type: No intervention / usual condition Timing: 30 min Duration Procedure: Participants rest quietly for the same pre-exercise duration without wearing a cooling vest, then complete the identical warm-up and exercise protocol.

  • DeviceWater Cooled Vest

    Type: Device (active cooling garment) Timing: 30 minutes before exercise (pre-cooling period) Procedure: Participants wear the water cooled vest in a hot/humid lab setting before the endurance aerobic exercise test. Purpose: Reduce thermal strain and cardiovascular load; improve comfort; modulate peripheral circulation responses.

06

What researchers measure

Primary outcomes

  1. Heart Rate

    Time frame: During a single laboratory visit lasting approx. 40 minutes: baseline immediately before the pre cooling period,immediately after 30 minutes of pre cooling,immediately after the 5 minute exercise bout, and immediately after the 5 minute seated cool down.

  2. Temperature

    Time frame: During a single laboratory visit lasting approx.40 minutes: baseline immediately before the pre cooling period, immediately after 30 minutes of pre cooling,immediately after the 5 minute exercise bout, and immediately after the 5 minute seated cool down.

07

Study locations

1 site
  • Cooling Vest
    Kaohsiung City, Sanmin 807, Taiwan
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Feb 2026 (actual). Primary completion is estimated for Feb 2027, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2026
First posted
Apr 20, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Feb 2027
CompletionEst.
May 2027
Last update
Apr 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07539714
Lead sponsor
Kaohsiung Medical University
Responsible party
Ayesha Areeba (Principal Investigator, Kaohsiung Medical University) — Principal investigator
First posted
Apr 20, 2026
Start date
Feb 1, 2026
Primary completion
Feb 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Apr 20, 2026

Study contacts

Guo LY Professor and Dean of College of Health Sciences, P.hD
study chair · Department of Sports Medicine, Kaohsiung Medical University, Taiwan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion